Lupin launches Sacubitril and Valsartan Combination Drug for Heart Failure Patients

18 Jan 2023 Evaluate

Lupin has launched combination drug Sacubitril and Valsartan under two brand names, Valentas and Arnipin, in India. This drug combination is indicated for patients with Heart Failure (HF) conditions. Valentas and Arnipin tablets are available in 200 mg, 100 mg, and 50 mg. Valentas and Arnipin are indicated to reduce repeated hospitalization and the risk of cardiovascular death among adult patients with chronic mild to moderate heart failure.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2175.50 9.40 (0.43%)
21-Jan-2026 10:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1622.10
Dr. Reddys Lab 1153.05
Cipla 1368.90
Zydus Lifesciences 874.40
Lupin 2175.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×